Family Medicine · Superior, AZ
NPI
1720071384
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1134 W US Highway 60
Superior, AZ, 85173
Phone (520) 689-2423
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$548K
5,916 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Douglas J Campbell prescribed most often to Medicare patients was Atorvastatin Calcium, with 248 prescriptions and refills. In total Douglas J Campbell wrote 5,916 Medicare prescriptions that cost $548K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 248 | 725 | 79 | $2,076 |
| Lisinopril Generic | 238 | 636 | 83 | $1,376 |
| Levothyroxine Sodium Generic | 220 | 543 | 59 | $1,731 |
| Amlodipine Besylate Generic | 212 | 602 | 77 | $1,446 |
| Losartan Potassium Generic | 208 | 582 | 64 | $1,735 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 195 | 288 | 62 | $5,219 |
| Gabapentin Generic | 187 | 385 | 62 | $4,345 |
| Metoprolol Succinate Generic | 186 | 454 | 63 | $1,945 |
| Omeprazole Generic | 169 | 431 | 61 | $2,654 |
| Metformin Hcl Generic | 164 | 474 | 57 | $1,125 |
| Hydrochlorothiazide Generic | 139 | 395 | 48 | $585 |
| Tamsulosin Hcl Generic | 122 | 311 | 40 | $1,857 |
| Furosemide Generic | 99 | 239 | 46 | $579 |
| Sertraline Hcl Generic | 85 | 183 | 32 | $552 |
| Bupropion Xl Bupropion Hcl | 85 | 167 | 21 | $1,774 |
Brand drugs: 718 claims; generic drugs: 5,164 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Douglas J Campbell were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.